|
89
|
308
|
3l8pA |
Crystal structure of cytoplasmic kinase domain of tie2 complexed with inhibitor cep11207 |
|
19
|
59
|
3kkaC |
Co-crystal structure of the sam domains of epha1 and epha2 |
|
87
|
318
|
3krjA |
Cfms tyrosine kinase in complex with 4-cyano-1h-imidazole-2-carboxylic acid (2-cyclohex-1-enyl-4-piperidin-4-yl-phenyl)-amide |
|
69
|
297
|
3kexA |
Crystal structure of the catalytically inactive kinase domain of the human epidermal growth factor receptor 3 (her3) |
|
19
|
64
|
3kkaA |
Co-crystal structure of the sam domains of epha1 and epha2 |
|
84
|
315
|
3krlA |
Cfms tyrosine kinase in complex with 5-cyano-furan-2-carboxylic acid [4-(4-methyl-piperazin-1-yl)-2-piperidin-1-yl-phenyl]-amide |
|
83
|
273
|
3kulB |
Kinase domain of human ephrin type-a receptor 8 (epha8) |
|
88
|
302
|
3js2A |
Crystal structure of minimal kinase domain of fibroblast growth factor receptor 1 in complex with 5-(2-thienyl)nicotinic acid |
|
80
|
325
|
3ikaA |
Crystal structure of egfr 696-1022 t790m mutant covalently binding to wz4002 |
|
93
|
302
|
3i81A |
Crystal structure of insulin-like growth factor 1 receptor (igf-1r-wt) complex with bms-754807 [1-(4-((5-cyclopropyl-1h-pyrazol-3-yl)amino)pyrrolo[2,1-f][1,2,4]triazin-2-yl)-n-(6-fluoro-3-pyridinyl)-2-methyl-l-prolinamide] |
|
30
|
174
|
3hpnA |
Ligand recognition by a-class eph receptors: crystal structures of the epha2 ligand-binding domain and the epha2/ephrin-a1 complex |
|
87
|
295
|
3i5nA |
Crystal structure of c-met with triazolopyridazine inhibitor 13 |
|
90
|
356
|
3hngA |
Crystal structure of vegfr1 in complex with n-(4-chlorophenyl)-2-((pyridin-4-ylmethyl)amino)benzamide |
|
144
|
547
|
3i2tA |
Crystal structure of the unliganded drosophila epidermal growth factor receptor ectodomain |
|
41
|
141
|
3hklA |
Crystal structure of the frizzled-like cysteine-rich domain of musk |
|
23
|
71
|
3h8mA |
Sam domain of human ephrin type-a receptor 7 (epha7) |
|
19
|
63
|
3hilA |
Sam domain of human ephrin type-a receptor 1 (epha1) |
|
60
|
193
|
3h3bA |
Crystal structure of the single-chain fv (scfv) fragment of an anti-erbb2 antibody cha21 in complex with residues 1-192 of erbb2 extracellular domain |
|
37
|
174
|
3heiA |
Ligand recognition by a-class eph receptors: crystal structures of the epha2 ligand-binding domain and the epha2/ephrin-a1 complex |
|
30
|
175
|
3gxuA |
Crystal structure of eph receptor and ephrin complex |
|
84
|
312
|
3gqlA |
Crystal structure of activated receptor tyrosine kinase in complex with substrates |
|
82
|
315
|
3gt8A |
Crystal structure of the inactive egfr kinase domain in complex with amp-pnp |
|
90
|
343
|
3gopA |
Crystal structure of the egf receptor juxtamembrane and kinase domains |
|
86
|
307
|
3gqiA |
Crystal structure of activated receptor tyrosine kinase in complex with substrates |
|
85
|
307
|
3g0fA |
Kit kinase domain mutant d816h in complex with sunitinib |
|
2
|
16
|
3g5yE |
Antibodies specifically targeting a locally misfolded region of tumor associated egfr |
|
90
|
298
|
3fy2A |
Human epha3 kinase and juxtamembrane region bound to substrate kqwdnyefiw |
|
104
|
332
|
3g0eA |
Kit kinase domain in complex with sunitinib |
|
96
|
299
|
3fxxA |
Human epha3 kinase and juxtamembrane region bound to substrate kqwdnye[ptyr]iw |
|
2
|
16
|
3g5vC |
Antibodies specifically targeting a locally misfolded region of tumor associated egfr |
|
81
|
306
|
3f82A |
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with n-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide |
|
93
|
298
|
3f66A |
Human c-met kinase in complex with quinoxaline inhibitor |
|
90
|
504
|
3fl7A |
Crystal structure of the human ephrin a2 ectodomain |
|
85
|
307
|
3f5pA |
Complex structure of insulin-like growth factor receptor and 3-cyanoquinoline inhibitor |
|
104
|
312
|
3ewhA |
Crystal structure of the vegfr2 kinase domain in complex with a pyridyl-pyrimidine benzimidazole inhibitor |
|
22
|
100
|
3euuA |
Crystal structure of the fgfr2 d2 domain |
|
31
|
187
|
3etpA |
The crystal structure of the ligand-binding domain of the ephb2 receptor at 2.0 a resolution |
|
97
|
294
|
3etaA |
Kinase domain of insulin receptor complexed with a pyrrolo pyridine inhibitor |
|
87
|
303
|
3ekkA |
Insulin receptor kinase complexed with an inhibitor |
|
82
|
298
|
3efjA |
Structure of c-met with pyrimidone inhibitor 7 |
|
86
|
298
|
3efkA |
Structure of c-met with pyrimidone inhibitor 50 |
|
46
|
277
|
3ejjX |
Structure of m-csf bound to the first three domains of fms |
|
85
|
300
|
3eknA |
Insulin receptor kinase complexed with an inhibitor |
|
92
|
312
|
3eflA |
Crystal structure of the vegfr2 kinase domain in complex with motesanib |
|
99
|
311
|
3dtwA |
Crystal structure of the vegfr2 kinase domain in complex with a benzisoxazole inhibitor |
|
92
|
296
|
3dzqA |
Human epha3 kinase domain in complex with inhibitor awl-ii-38.3 |
|
86
|
312
|
3dpkA |
Cfms tyrosine kinase in complex with a pyridopyrimidinone inhibitor |
|
93
|
312
|
3dkfA |
Structure of met receptor tyrosine kinase in complex with inhibitor sgx-523 |
|
85
|
296
|
3dkoA |
Complex between the kinase domain of human ephrin type-a receptor 7 (epha7) and inhibitor alw-ii-49-7 |
|
101
|
312
|
3dkcA |
Structure of met receptor tyrosine kinase in complex with atp |
